DSGN
Design Therapeutics Inc
12.30$
-0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -16.7% | -3,835,840.7% | – | – | – | – | – | |
| 0.6% | 2,212.4% | – | – | – | – | – | |
| 0.0% | 199,115.0% | – | – | – | – | – | |
| 11.4% | 184,513.3% | – | – | – | – | – | |
| 217.4% | -358,849.6% | – | – | – | – | – | |
| 9.1% | 33,628.3% | – | – | – | – | – | |
| -4,024.1% | -14,850,000.0% | – | – | – | – | – | |
| 23.5% | -88,495.6% | – | – | – | – | – | |
| 23.5% | 19,704,424.8% | – | – | – | – | – | |
| 6.8% | 1,018,584.1% | – | – | – | – | – | |
| -16.7% | -3,869,469.0% | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.